Annual Working Capital
$12.92 M
-$17.32 M-57.28%
December 31, 2023
Summary
- As of February 12, 2025, MTNB annual working capital is $12.92 million, with the most recent change of -$17.32 million (-57.28%) on December 31, 2023.
- During the last 3 years, MTNB annual working capital has fallen by -$45.07 million (-77.72%).
- MTNB annual working capital is now -77.72% below its all-time high of $57.99 million, reached on December 31, 2020.
Performance
MTNB Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$9.62 M
-$3.28 M-25.41%
September 30, 2024
Summary
- As of February 12, 2025, MTNB quarterly working capital is $9.62 million, with the most recent change of -$3.28 million (-25.41%) on September 30, 2024.
- Over the past year, MTNB quarterly working capital has dropped by -$7.14 million (-42.62%).
- MTNB quarterly working capital is now -86.54% below its all-time high of $71.45 million, reached on March 31, 2020.
Performance
MTNB Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
MTNB Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -57.3% | -42.6% |
| 3 y3 years | -77.7% | -42.6% |
| 5 y5 years | +26.1% | -42.6% |
MTNB Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -72.3% | at low | -79.4% | +16.0% |
| 5 y | 5-year | -77.7% | at low | -86.5% | +16.0% |
| alltime | all time | -77.7% | +666.0% | -86.5% | +1793.1% |
Matinas BioPharma Holdings Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $9.62 M(-25.4%) |
| Jun 2024 | - | $12.89 M(+55.5%) |
| Mar 2024 | - | $8.29 M(-35.8%) |
| Dec 2023 | $12.92 M(-57.3%) | $12.92 M(-22.9%) |
| Sep 2023 | - | $16.76 M(-21.7%) |
| Jun 2023 | - | $21.41 M(-18.6%) |
| Mar 2023 | - | $26.31 M(-13.0%) |
| Dec 2022 | $30.25 M(-35.2%) | $30.25 M(-6.1%) |
| Sep 2022 | - | $32.20 M(-11.9%) |
| Jun 2022 | - | $36.54 M(-11.6%) |
| Mar 2022 | - | $41.35 M(-11.4%) |
| Dec 2021 | $46.65 M(-19.6%) | $46.65 M(-11.0%) |
| Sep 2021 | - | $52.38 M(-8.7%) |
| Jun 2021 | - | $57.35 M(-5.9%) |
| Mar 2021 | - | $60.91 M(+5.0%) |
| Dec 2020 | $57.99 M(+116.2%) | $57.99 M(-7.0%) |
| Sep 2020 | - | $62.36 M(-6.6%) |
| Jun 2020 | - | $66.80 M(-6.5%) |
| Mar 2020 | - | $71.45 M(+166.3%) |
| Dec 2019 | $26.83 M | $26.83 M(-15.2%) |
| Sep 2019 | - | $31.63 M(-6.9%) |
| Jun 2019 | - | $33.96 M(-7.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $36.79 M(+259.1%) |
| Dec 2018 | $10.25 M(+65.4%) | $10.25 M(+109.7%) |
| Sep 2018 | - | $4.89 M(-37.8%) |
| Jun 2018 | - | $7.85 M(+103.2%) |
| Mar 2018 | - | $3.86 M(-37.6%) |
| Dec 2017 | $6.19 M(+98.5%) | $6.19 M(-25.3%) |
| Sep 2017 | - | $8.29 M(-20.3%) |
| Jun 2017 | - | $10.40 M(-29.9%) |
| Mar 2017 | - | $14.84 M(+375.6%) |
| Dec 2016 | $3.12 M(+28.4%) | $3.12 M(-39.6%) |
| Sep 2016 | - | $5.17 M(-1010.0%) |
| Jun 2016 | - | -$568.00 K(-196.0%) |
| Mar 2016 | - | $591.60 K(-75.7%) |
| Dec 2015 | $2.43 M(+44.1%) | $2.43 M(-39.4%) |
| Sep 2015 | - | $4.01 M(-30.2%) |
| Jun 2015 | - | $5.74 M(+62.6%) |
| Mar 2015 | - | $3.53 M(+109.4%) |
| Dec 2014 | $1.69 M(-83.2%) | $1.69 M(-58.8%) |
| Sep 2014 | - | $4.09 M(-29.6%) |
| Jun 2014 | - | $5.81 M(-27.1%) |
| Mar 2014 | - | $7.97 M(-20.8%) |
| Dec 2013 | $10.07 M | $10.07 M |
FAQ
- What is Matinas BioPharma Holdings annual working capital?
- What is the all time high annual working capital for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings annual working capital year-on-year change?
- What is Matinas BioPharma Holdings quarterly working capital?
- What is the all time high quarterly working capital for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings quarterly working capital year-on-year change?
What is Matinas BioPharma Holdings annual working capital?
The current annual working capital of MTNB is $12.92 M
What is the all time high annual working capital for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high annual working capital is $57.99 M
What is Matinas BioPharma Holdings annual working capital year-on-year change?
Over the past year, MTNB annual working capital has changed by -$17.32 M (-57.28%)
What is Matinas BioPharma Holdings quarterly working capital?
The current quarterly working capital of MTNB is $9.62 M
What is the all time high quarterly working capital for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high quarterly working capital is $71.45 M
What is Matinas BioPharma Holdings quarterly working capital year-on-year change?
Over the past year, MTNB quarterly working capital has changed by -$7.14 M (-42.62%)